Clinical Trials Logo

Clinical Trial Summary

To evaluate the degree of acute and long-term intestinal, urinary and vaginal toxicity, and the impact on sexual activity of an accelerated fractionation of high dose rate interventional radiotherapy (IRT-HDR) in patients with locally advanced cervical cancer (IB2 - VA, N+/-).


Clinical Trial Description

Observational, monocentric and prospective study. All patients with locally advanced cervix cancer will be underwent to radiochemotherapy followed by accelerated interventional radiotherapy (brachytherapy). Fist endpoints wer severe acute and late gastrointestinal, and urinary toxicities and sexual activity. ;


Study Design


Related Conditions & MeSH terms

  • Carcinoma
  • Locally Advanced Cervical Carcinoma

NCT number NCT06398938
Study type Observational
Source Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Contact VALENTINA LANCELLOTTA
Phone 3441177911
Email valentina.lancellotta@policlinicogemelli.it
Status Not yet recruiting
Phase
Start date May 6, 2024
Completion date December 30, 2026

See also
  Status Clinical Trial Phase
Recruiting NCT05406856 - PROTECT: On-line Adaptive Proton Therapy for Cervical Cancer N/A
Recruiting NCT05269381 - Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors Phase 1
Recruiting NCT05462379 - Autologous Heterotopic Fresh Ovarian Graft in Woman With LACC Eligible for Pelvic Radiotherapy Treatment. Phase 1/Phase 2
Recruiting NCT05235516 - A Study of AK104/Placebo Combined With Chemoradiotherapy For The Treatment of Locally Advanced Cervical Cancer Phase 3
Not yet recruiting NCT05210270 - HYpofractionated Pelvic Radiotherapy for Advanced Cervical Cancers INeligible for ChemoTherapy Phase 1/Phase 2
Recruiting NCT05722288 - Time-Restricted Eating Versus Nutritional Counseling for the Reduction of Radiation or Chemoradiation Tx Side Effects in Patients With Prostate, Cervical, or Rectal Cancers Phase 2
Recruiting NCT06391190 - Concurrent Chemoradiotherapy Followed by PD-1 Inhibitor in Advanced Cervical Cancer Phase 1/Phase 2
Recruiting NCT06378840 - the Predictive Value of Immune Cell in Locally Advanced Cervical Cancer
Recruiting NCT05701735 - Decision Aid for Chemotherapy in Cisplatin-Intolerant Patients With Locally Advanced Cervical Cancer N/A
Recruiting NCT05975593 - MicroEnvironment Tumor Effects of Radiotherapy - Comprehensive Radiobiology Assessment TRial
Recruiting NCT06349642 - Predicting Response to Immune Checkpoint Inhibitors Across Solid Tumors Using a Live Tumor Diagnostic Platform
Not yet recruiting NCT04789941 - How To Evaluate The Efficiency And Safety Of Neoadjuvant Chemotherapy In Locally Advanced Cancer Cervix Phase 2